Cefprozil |
Cefzil |
Article: Cefprozil
![]() | |
| Cefprozil | |
| Systematic (IUPAC) name | |
| 8-[2-amino-2-(4-hydroxyphenyl)-acetyl] amino-7-oxo-4-prop-1-enyl-2-thia-6- azabicyclo [ 4.2.0]oct-4-ene-5-carboxylic acid | |
| Identifiers | |
| CAS number | 92665-29-7 |
| ATC code | J01DC10 |
| PubChem | 5281006 |
| DrugBank | APRD00461 |
| Chemical data | |
| Formula | C18H19N3O5S |
| Mol. weight | 389.427 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 36% |
| Metabolism | ? |
| Half life | 1.3 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Cefprozil, sometimes spelled cefproxil and sold under the brand name Cefzil, is a cephalosporin antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Not Signed In - 

